Bicycle Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BCYC Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
11 Apr 24	BuyUS$50,167,808	Baker Bros. Advisors LP	Company		1,952,617	US$25.69

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BCYC?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	411	0.000597%
Individual Insiders	560,345	0.814%
VC/PE Firms	3,490,506	5.07%
General Public	6,918,231	10%
Institutions	27,255,223	39.6%
Hedge Funds	30,631,343	44.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 129.2%.

Top Shareholders

Top 25 shareholders own 84.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
44.5%	Baker Bros. Advisors LP	30,631,343	US$621.5m	431%	7.35%
5.07%	Deep Track Capital, LP	3,490,506	US$70.8m	0%	2.02%
4.72%	Paradigm Biocapital Advisors LP	3,246,759	US$65.9m	-12.4%	2.66%
3.27%	RA Capital Management, L.P.	2,253,000	US$45.7m	182%	0.63%
2.54%	Cambridge Innovation Capital Jersey Limited	1,751,437	US$35.5m	0%	no data
2.43%	Armistice Capital LLC	1,672,000	US$33.9m	8.85%	0.99%
2.24%	Tybourne Capital Management (HK) Ltd.	1,545,026	US$31.3m	-6.38%	5.8%
2.22%	SR One Capital Management, LP	1,529,561	US$31.0m	0%	9.27%
2.2%	Morgan Stanley, Investment Banking and Brokerage Investments	1,516,438	US$30.8m	47.4%	no data
1.73%	First Light Asset Management, LLC	1,193,051	US$24.2m	-23.1%	2.2%
1.51%	Westfield Capital Management Company, L.P.	1,038,917	US$21.1m	13.3%	0.11%
1.46%	Polar Capital Holdings Plc	1,004,535	US$20.4m	0%	0.08%
1.33%	Suvretta Capital Management, LLC	914,476	US$18.6m	0%	0.79%
1.29%	Candriam	889,258	US$18.0m	2.3%	0.05%
1.28%	BNPP Asset Management Holding	883,105	US$17.9m	12.8%	0.02%
0.84%	BlackRock, Inc.	575,030	US$11.7m	14.6%	no data
0.8%	AXA Investment Managers S.A.	554,163	US$11.2m	0.01%	0.02%
0.76%	Parkman Healthcare Partners LLC	524,253	US$10.6m	67.6%	1.41%
0.65%	Camber Capital Management LP	450,000	US$9.1m	0%	0.33%
0.61%	Schonfeld Strategic Advisors LLC	420,800	US$8.5m	293%	0.07%
0.58%	T. Rowe Price Group, Inc.	401,646	US$8.1m	45.1%	no data
0.58%	Bank of America Corporation, Asset Management Arm	396,812	US$8.1m	-14%	no data
0.51%	Point72 Asset Management, L.P.	352,014	US$7.1m	3.6%	0.02%
0.5%	Verition Fund Management LLC	340,866	US$6.9m	-54%	0.08%
0.48%	Platinum Investment Management Limited	333,001	US$6.8m	-8.03%	0.19%